![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 22, 13751-13757, Nov, 1984
K Nakazawa, JR Hassell, VC Hascall, LS Lohmander, DA Newsome and J Krachmer
Macular corneal dystrophy is a human genetic disorder characterized by
corneal opacities that arise, in part, from a failure to synthesize mature
keratan sulfate proteoglycans. The macromolecules in macular corneas and in
keratoconus corneas, an abnormality not involving proteoglycans, were
biosynthetically labeled with [3H]mannose and [14C]glucosamine in organ
culture, and the keratan sulfate proteoglycans were immunoprecipitated with
antibodies against the protein core of monkey keratan sulfate proteoglycan.
The chondroitin sulfate proteoglycans, which did not react with the
antibody, were oversulfated in corneas from patients with macular corneal
dystrophy. Characterization of the immunoprecipitates showed that macular
corneas did not make keratan sulfate proteoglycan but did synthesize an
immunoreactive glycoprotein in nearly equal amounts as keratan sulfate
proteoglycan was synthesized by the keratoconus cornea. The
oligosaccharides on the immunoprecipitated macular glycoprotein appeared to
be normal. However, the macromolecules contained an unsulfated
glycoconjugate that was nearly as large as the normal keratan sulfate
chains isolated from the keratoconus keratan sulfate- proteoglycan and
contained the same relative proportions of labeled glucosamine, mannose,
and fucose. This glycoconjugate was resistant to digestion with keratanase.
These observations indicate that macular corneal dystrophy is caused by an
error in the synthesis of keratan sulfate, possibly involving the specific
sulfotransferases involved in sulfation of the lactosaminoglycan backbone
of the chains.
Defective processing of keratan sulfate in macular corneal dystrophy
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
N. Beecher, S. Chakravarti, S. Joyce, K. M. Meek, and A. J. Quantock Neonatal Development of the Corneal Stroma in Wild-Type and Lumican-Null Mice Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 146 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Funderburgh, M. M. Mann, and M. L. Funderburgh Keratocyte Phenotype Mediates Proteoglycan Structure: A ROLE FOR FIBROBLASTS IN CORNEAL FIBROSIS J. Biol. Chem., November 14, 2003; 278(46): 45629 - 45637. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iida-Hasegawa, A. Furuhata, H. Hayatsu, A. Murakami, K. Fujiki, K. Nakayasu, and A. Kanai Mutations in the CHST6 Gene in Patients with Macular Corneal Dystrophy: Immunohistochemical Evidence of Heterogeneity Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3272 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. El-Ashry, M. M. A. El-Aziz, S. Wilkins, M. E. Cheetham, S. E. Wilkie, A. J. Hardcastle, S. Halford, A. Y. Bayoumi, L. A. Ficker, S. Tuft, et al. Identification of Novel Mutations in the Carbohydrate Sulfotransferase Gene (CHST6) Causing Macular Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 377 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuda, N. Hiraoka, T. O. Akama, and M. N. Fukuda Carbohydrate-modifying Sulfotransferases: Structure, Function, and Pathophysiology J. Biol. Chem., December 14, 2001; 276(51): 47747 - 47750. [Full Text] [PDF] |
||||
![]() |
A. H. Plaas, L. A. West, E. J. A. Thonar, Z. A. Karcioglu, C. J. Smith, G. K. Klintworth, and V. C. Hascall Altered Fine Structures of Corneal and Skeletal Keratan Sulfate and Chondroitin/Dermatan Sulfate in Macular Corneal Dystrophy J. Biol. Chem., October 19, 2001; 276(43): 39788 - 39796. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hasegawa, T. Torii, T. Kato, H. Miyajima, A. Furuhata, K. Nakayasu, A. Kanai, and O. Habuchi Decreased GlcNAc 6-O-Sulfotransferase Activity in the Cornea with Macular Corneal Dystrophy Invest. Ophthalmol. Vis. Sci., November 1, 2000; 41(12): 3670 - 3677. [Abstract] [Full Text] |
||||
![]() |
D. Lewis, Y. Davies, I. A. Nieduszynski, F. Lawrence, A. J. Quantock, R. Bonshek, and N. J. Fullwood Ultrastructural localization of sulfated and unsulfated keratan sulfate in normal and macular corneal dystrophy type I Glycobiology, March 1, 2000; 10(3): 305 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Beales, J. L. Funderburgh, J. V. Jester, and J. R. Hassell Proteoglycan Synthesis by Bovine Keratocytes and Corneal Fibroblasts: Maintenance of the Keratocyte Phenotype in Culture Invest. Ophthalmol. Vis. Sci., July 1, 1999; 40(8): 1658 - 1663. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Dunlevy, P. J. Neame, J.-P. Vergnes, and J. R. Hassell Identification of the N-Linked Oligosaccharide Sites in Chick Corneal Lumican and Keratocan That Receive Keratan Sulfate J. Biol. Chem., April 17, 1998; 273(16): 9615 - 9621. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukuta, J. Inazawa, T. Torii, K. Tsuzuki, E. Shimada, and O. Habuchi Molecular Cloning and Characterization of Human Keratan Sulfate Gal-6-Sulfotransferase J. Biol. Chem., December 19, 1997; 272(51): 32321 - 32328. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ying, A. Shiraishi, C. W.-C. Kao, R. L. Converse, J. L. Funderburgh, J. Swiergiel, M. R Roth, G. W. Conrad, and W. W.-Y. Kao Characterization and Expression of the Mouse Lumican Gene J. Biol. Chem., November 28, 1997; 272(48): 30306 - 30313. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Akama, J. Nakayama, K. Nishida, N. Hiraoka, M. Suzuki, J. McAuliffe, O. Hindsgaul, M. Fukuda, and M. N. Fukuda Human Corneal GlcNAc 6-O-Sulfotransferase and Mouse Intestinal GlcNAc 6-O-Sulfotransferase Both Produce Keratan Sulfate J. Biol. Chem., May 4, 2001; 276(19): 16271 - 16278. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |